The people who write in happy, more often than not, took a moderate, steady dose alongside vitamin C, every morning, for at least a month before judging results
Heatmap of C4 subtype-specific protein signature applied to Jayavelu et al
Interestingly, miR-155 is already entering a clinical phase trial as a therapeutic compound registered by Miragen Therapeutics against Amyotrophic lateral sclerosis (Chakraborty et al., 2021)
It does not stimulate muscle protein synthesis on its own, and it does not act on androgen receptors
& ala-Mutlu, Z
PRIMA-1 has been reported to inhibit carcinogenesis and promote the expression of target genes such as Puma, Bax, and CDKN1A